Company / Net Income
Travere Therapeutics, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$25.5M
FY2025
5-year range
-$321.5M / -$25.5M
FY2021-FY2025
Trend
+92.1%
vs FY2024
Sector context
#74 of 216
Health Care
What the data says
At -$26M, Travere Therapeutics, Inc.'s net income ranks #74 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$322M in FY2024 to $117M in FY2017.
Based on SEC 10-K filings.
-$26M in FY2025.
Improved from -$111M to -$26M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#74 of 216 in Health CareTop 34% of 216This company -$25.5M Sector average $454.3M
▼
-105.6% below sector average
Key checks
Key Insights
- In FY2025, net income increased 92.1% year-over-year.
- Ranks #74 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2017.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$25.5M | +92.1% |
| FY2024 | -$321.5M | -188.6% |
| FY2023 | -$111.4M | +60.0% |
| FY2022 | -$278.5M | -90.2% |
| FY2021 | -$146.4M | -42.6% |
| FY2020 | -$102.7M | -71.9% |
| FY2019 | -$59.7M | -24.7% |
| FY2018 | -$47.9M | -140.9% |
| FY2017 | $117.2M | +205.7% |
| FY2016 | -$110.9M | -194.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026